These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39079462)

  • 1. Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment.
    Chu X; Mi B; Xiong Y; Wang R; Liu T; Hu L; Yan C; Zeng R; Lin J; Fu H; Liu G; Zhang K; Bian L
    Biomaterials; 2025 Jan; 312():122714. PubMed ID: 39079462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin-Microsphere/IR820 Hybrid Bifunctional Hydrogels for In Situ Osteosarcoma Chemo-
    Tan B; Wu Y; Wu Y; Shi K; Han R; Li Y; Qian Z; Liao J
    ACS Appl Mater Interfaces; 2021 Jul; 13(27):31542-31553. PubMed ID: 34191477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-Sequential and Multi-Functional 3D Printed MgO
    Li C; Zhang W; Nie Y; Du X; Huang C; Li L; Long J; Wang X; Tong W; Qin L; Lai Y
    Adv Mater; 2024 Aug; 36(34):e2308875. PubMed ID: 38091500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocomposite hydrogels stabilized by self-assembled multivalent bisphosphonate-magnesium nanoparticles mediate sustained release of magnesium ion and promote in-situ bone regeneration.
    Zhang K; Lin S; Feng Q; Dong C; Yang Y; Li G; Bian L
    Acta Biomater; 2017 Dec; 64():389-400. PubMed ID: 28963020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy.
    Yu W; Wang Y; Zhu J; Jin L; Liu B; Xia K; Wang J; Gao J; Liang C; Tao H
    Biomaterials; 2019 Feb; 192():128-139. PubMed ID: 30448697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
    He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
    Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
    Cao J; Zhu C; Cao Z; Ke X
    Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice.
    He X; Lin H; Yuan L; Li B
    Cancer Biol Ther; 2017 Feb; 18(2):94-100. PubMed ID: 28045576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of manganese and magnesium ions by microsphere-encapsulated hydrogel enhances cancer immunotherapy.
    Ma L; Wang X; Wu Y; Zhang Y; Yuan X; Mao J; Li Q; Gong S
    J Control Release; 2024 Aug; 372():682-698. PubMed ID: 38950681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint Blockade in Combination With Doxorubicin Augments Tumor Cell Apoptosis in Osteosarcoma.
    Wang J; Hu C; Wang J; Shen Y; Bao Q; He F; Wang H; Gong L; Liu Z; Hu F; Liang J; Zhou Q; Wei L; Wen J; Zhang W
    J Immunother; 2019; 42(9):321-330. PubMed ID: 31219973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel-Mediated Reprogramming of Cancer-Associated Fibroblasts in Osteosarcoma.
    Wang H; Chen Y; Wei R; Zhang J; Zhu J; Wang W; Wang Z; Wupur Z; Li Y; Meng H
    Adv Mater; 2024 Apr; 36(15):e2309591. PubMed ID: 38113900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic bone-periosteum scaffold for spatiotemporal regulated innervated bone regeneration and therapy of osteosarcoma.
    Xu Y; Xu C; Song H; Feng X; Ma L; Zhang X; Li G; Mu C; Tan L; Zhang Z; Liu Z; Luo Z; Yang C
    J Nanobiotechnology; 2024 May; 22(1):250. PubMed ID: 38750519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunitinib inhibits PD-L1 expression in osteosarcoma by targeting STAT3 and remodels the immune system in tumor-bearing mice.
    Duan XL; Guo JP; Li F; Xiu C; Wang H
    Future Oncol; 2020 Aug; 16(24):1815-1824. PubMed ID: 32511016
    [No Abstract]   [Full Text] [Related]  

  • 15. Engineering a triple-functional magnetic gel driving mutually-synergistic mild hyperthermia-starvation therapy for osteosarcoma treatment and augmented bone regeneration.
    Yu K; Zhou H; Xu Y; Cao Y; Zheng Y; Liang B
    J Nanobiotechnology; 2023 Jun; 21(1):201. PubMed ID: 37365598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced osteogenic and ROS-scavenging MXene nanosheets incorporated gelatin-based nanocomposite hydrogels for critical-sized calvarial defect repair.
    Zhao J; Wang T; Zhu Y; Qin H; Qian J; Wang Q; Zhang P; Liu P; Xiong A; Li N; Udduttula A; Ye SH; Wang D; Zeng H; Chen Y
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131914. PubMed ID: 38703527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MXene-Based Hydrogels Endow Polyetheretherketone with Effective Osteogenicity and Combined Treatment of Osteosarcoma and Bacterial Infection.
    Yin J; Han Q; Zhang J; Liu Y; Gan X; Xie K; Xie L; Deng Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45891-45903. PubMed ID: 33012164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clay-based nanocomposite hydrogel with attractive mechanical properties and sustained bioactive ion release for bone defect repair.
    Zhai X; Ruan C; Shen J; Zheng C; Zhao X; Pan H; Lu WW
    J Mater Chem B; 2021 Mar; 9(10):2394-2406. PubMed ID: 33625433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GO/Cu Nanosheet-Integrated Hydrogel Platform as a Bioactive and Biocompatible Scaffold for Enhanced Calvarial Bone Regeneration.
    Yang Y; Zhou B; Li M; Sun Y; Jiang X; Zhou X; Hu C; Zhang D; Luo H; Tan W; Yang X; Lei S
    Int J Nanomedicine; 2024; 19():8309-8336. PubMed ID: 39161358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma.
    Wang J; Hu F; Yu P; Wang J; Liu Z; Bao Q; Zhang W; Wen J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5127-5138. PubMed ID: 36348018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.